Advancing RNA-Based Therapeutics Using a Structural Nanomedicine Approach

• Pioneering a structural nanomedicine platform designed to optimize delivery and therapeutic performance across mRNA and other therapeutic modalities
• Demonstrating examples of enhanced mRNA delivery and efficiency using structural nanomedicine, outperforming conventional LNP
• Highlighting recent program updates with expanded non-clinical data in oncology and CRISPR-based gene editing applications

Speakers:

Alex Anderson

Senior Scientist

Flashpoint Therapeutics